An Examination of Moderna
DOI:
https://doi.org/10.33423/jabe.v26i5.7357Keywords:
business, economicsAbstract
Understanding the COVID-19 response for Moderna, a biotechnology company based out of the United States, and compiling the current outlooks regarding vaccinations, development of a diversified product line, and garnering a competitive edge in the biotechnology space is a costly endeavor Moderna is attempting to transverse. Declining revenues, rising costs, and low sales of Moderna's current product have deteriorated the value base. The recent increase in share price is motivated by anticipation of a potential avian flu outbreak and response. This study attempts to shed light on the current financial condition of Moderna.
References
Berniato, S. (2022, September 16). Moderna v. Pfizer: What the patent infringement suit means for biotech. Harvard Business Review. Retrieved from https://hbr.org/2022/09/moderna-v-pfizer-what-the-patent-infringement-suit-means-for-biotech#:~:text=Covid%20vaccine%20producer%20Moderna%20has%20sued%20fellow%20vaccine,may%20start%20enforcing%20its%20patents%20in%20higher-income%20countries.
Business Wire. (2020, October 8). DARPA awards moderna up to $56 million to enable small-scale, rapid mobile manufacturing of Nucleic Acid Vaccines and therapeutics.
Chadha, J. (2023, April 3). Key pharma trends in 2023. Pharma Manufacturing. Retrieved from https://www.pharmamanufacturing.com/home/article/33002742/key-pharma-trends-in-2023
Dillinger, K. (2023, December 14). Experimental cancer vaccine, combined with immunotherapy, continues to show benefits against melanoma, trial shows. CNN.
J.P. Morgan. (2023a, December). 2023 annual Biopharma Licensing and Venture Report. Retrieved from https://www.jpmorgan.com/content/dam/jpmorgan/documents/cb/insights/outlook/jpmorgan-dec-2023-biopharma-licensing-and-venture-report.pdf
Kazis, J. (2024, May). Moderna and Pfizer in Talks With U.S. To Make a Bird Flu Vaccine. MSN. Retrieved from https://www.msn.com/en-us/health/other/moderna-and-pfizer-in-talks-with-u-s-to-make-a-bird-flu-vaccine/ar-BB1mSaK2
Kenilworth, N.J., & Cambridge Mass. (2016). Merck and Moderna announce strategic collaboration to advance novel mrna-based personalized cancer vaccines with Keytruda® (pembrolizumab) for the treatment of multiple types of cancer. Retrieved from https://investors.modernatx.com:443/news/news-details/2016/Merck-and-Moderna-Announce-Strategic-Collaboration-to-Advance-Novel-mRNA-Based-Personalized-Cancer-Vaccines-with-KEYTRUDA-pembrolizumab-for-the-Treatment-of-Multiple-Types-of-Cancer/default.aspx
Laise, E. (2024, May). Moderna’s stock climbs on report that Bird-flu vaccine. Retrieved from https://www.marketwatch.com/amp/story/modernas-stock-climbs-on-report-that-bird-flu-vaccine-funding-is-near-cf4f8d65
Macrotrends. (n.d.). Moderna Gross margin 2017-2024: Mrna. Retrieved from https://www.macrotrends.net/stocks/charts/MRNA/moderna/gross-margin
Manalac, T. (2024, May 20). Moderna gets win in covid-19 patent dispute with Pfizer, BioNTech. BioSpace. Retrieved from https://www.biospace.com/article/moderna-gets-win-in-covid-19-patent-dispute-with-pfizer-biontech/
Mikulic, M. (n.d.). Topic: Global Pharmaceutical Industry. Statista. Retrieved from https://www.statista.com/topics/1764/global-pharmaceutical-industry/#editorsPicks
Moderna, Corp. (2024, March). Moderna advances multiple vaccine programs to late-stage clinical trials. Retrieved from https://investors.modernatx.com/news/news-details/2024/Moderna-Advances-Multiple-Vaccine-Programs-to-Late-Stage-Clinical-Trials/default.aspx
Moderna, Inc. (2024b). (mRNA) latest stock news & headlines - yahoo finance. Retrieved from https://finance.yahoo.com/quote/MRNA/news/
Moderna. (2023b). Moderna to acquire Oriciro Genomics. Retrieved from https://investors.modernatx.com/news/news-details/2023/Moderna-to-Acquire-OriCiro-Genomics/default.aspx
Moderna. (2024a, March). Moderna and OpenAI Collaborate to advance mRNA medicine. Retrieved from https://investors.modernatx.com/news/news-details/2024/Moderna-and-OpenAI-Collaborate-To-Advance-mRNA-Medicine/default.aspx
Mole, B. (2023, February 24). As Covid Vaccine Patent Dispute Drags on, Moderna Forks over $400m to NIH. Ars Technica. Retrieved from https://arstechnica.com/science/2023/02/moderna-forks-over-400m-to-nih-amid-dispute-over-covid-vaccine-ip/
MRNA | moderna inc.. company profile & executives - WSJ. (2024c).
Pomeroy, R. (2023, November 1). How ai played an instrumental role in making mrna vaccines. Big Think. Retrieved from https://bigthink.com/health/ai-mrna-vaccines-moderna/#:~:text=Johnson%20and%20his%20team%20put%20AI%20and%20automated,body%20%E2%80%94%20more%20bang%20for%20the%20biological%20buck.
Sweeney, J. (2024, January 10). At Moderna, a CFO vows to de-risk R&D as mrna tech promises to shorten success path. Forbes. Retrieved from https://www.forbes.com/sites/jacksweeney/2024/01/10/at-moderna-a-cfo-vows-to-de-risk-rd-as-mrna-tech-promises-to-shorten-success-path/?sh=31cae0df7b3f
Vertex Pharmaceuticals. (2020, September 16). Moderna and vertex establish new collaboration to treat cystic fibrosis using gene editing. Retrieved from https://investors.vrtx.com/news-releases/news-release-details/moderna-and-vertex-establish-new-collaboration-treat-cystic
Wexler, M. (2024, January 10). Phase 3 trials of new triple-combo CFTR modulator to report results. Cystic Fibrosis News Today. Retrieved from https://cysticfibrosisnewstoday.com/news/phase-3-trials-new-triple-combo-cftr-modulator-report-results/
Wingrove, P. (2023, December). Exclusive: US FDA finds control lapses at Moderna Manufacturing Plant. Reuters. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-finds-control-lapses-moderna-manufacturing-plant-2023-12-15/
Yahoo! (2024a, April). Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year. Yahoo! Finance. Retrieved from https://finance.yahoo.com/news/moderna-sales-only-product-covid-212106400.html?fr=sycsrp_catchall
Yahoo! (2024b, May). Decoding Moderna Inc (mRNA): A strategic swot insight. Yahoo! Finance. Retrieved from https://finance.yahoo.com/news/decoding-moderna-inc-mrna-strategic-050140891.html?fr=sycsrp_catchall
Yahoo! (2024c, May). Moderna reports first quarter 2024 financial results and provides business updates. Yahoo! Finance. Retrieved from https://finance.yahoo.com/news/moderna-reports-first-quarter-2024-103000644.html?fr=sycsrp_catchall
